Forget about the drug and that it works and it’s potential and forget about the directors and investors coming in at 7.5 cents
The fact that the market cap is now 9 million with 5.6 million in cash and 4 million coming in from R&D giving them 10 million in funding, now the company valued less than the cash they have access to now that’s funny
there are pennies that have no money and no potential worth more than NYR hahaha.
Ann: Nyrada Commences Walter Reed Traumatic Brain Injury Study, page-147
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
